CXCL13 and experimental autoimmune encephalomyelitis: In a murine model of experimental autoimmune encephalomyelitis, myelin-specific Tfh could not induce disease when transferred into recipient mice; however, anti-CXCL13 treatment (CXCL13: chemokine that binds to CXCR5, which is highly expressed on Tfh) attenuated Th17-mediated disease severity (21).